#cascade straining

[uberstrainer]

Optimize Cell Separation with pluriSelect Tubes

Navigate the world of precision filtration with our 70 μm cell strainer. Elevate your cell separation techniques effortlessly.

[uberstrainerusa]

What is TCR Therapy, CAR T Cell, and What are They Used For?

The antigen-binding theory is the foundation of CAR-T and TCR-T. Let's examine how their recognition and action characteristics vary.

Medical research and cancer treatment strategies are constantly evolving to meet new challenges. When more traditional cancer treatments fail, patients may resort to adoptive cell therapy as a last resort. 

Adoptive cell therapy combines human T cells with scientific enhancements to treat diseases that the body is ill-equipped to handle.

CAR T-cell therapy and engineered TCR therapy are two T-cell therapies that involve the modification of receptors for the purpose of cancer treatment.

We will discuss the Pluribead cascade straining and how it helps in the gentle separation of T cells.

Chimeric Antigen Receptors (CAR)

CAR T-cell therapy involves binding proteins called chimeric antigen receptors to patient-derived activated T cells. These receptors have been engineered to target naturally occurring antigens on the surface of cancer cells. This allows patients to receive treatment for cancers that the body cannot fight on its own.

CAR T Cell Activity

Currently, three types of FDA-approved CAR T-cell therapies are available for clinical use. These techniques have enabled the treatment of certain types of lymphoma and leukemia. 

Other receptor-antigen combinations are undergoing clinical trials. As research advances and more cell therapies are approved by the FDA, the number of cancers that can be treated grows.

TCR Cell Therapy Function

The MHC, or major histocompatibility complex, is a group of genes that code for antigens that the immune system can recognize. The MHC identifies foreign pathogens by attaching proteins to their surfaces that T lymphocytes can bind to. 

Engineered TCR therapy imbues activated T cells with specific receptors that target cancer antigens. This greatly improves treatment personalization and increases the likelihood of positive outcomes for patients.

TCR vs. CAR T

CAR T-cell therapy is a type of TCR therapy that has been engineered. While these two strategies have many similarities, their differences determine what purpose they serve. The receptors programmed into the cell are the main difference between CAR T-cell therapy and engineered TCR therapy. 

CAR T cells, as previously stated, have receptors that target naturally occurring antigens. The immune system plays no role in CAR T-cell therapy other than to lend T lymphocytes. TCR therapy, on the other hand, uses MHC to label cancer cells with identifiable antigens.

Pluribead For T Cells Separation

This research can be simplified by streamlining various stages of the manufacturing process. T-cell separation takes a long time and requires expensive equipment. 

Previously, researchers used complex machines to perform the time-consuming task of sorting and purifying large volumes of lymphocytes. Innovative cell separation strategies, such as Pluribeads, are more efficient and produce better results at a lower cost.

Pluribead cascade straining, which operates without the use of any magnetic components, aids in the gentle and safe isolation of Dendritic Cells. The procedure is straightforward: your pluriBeads (which contain bound target cells) are sieved through a strainer, with unwanted cells passing through and your target cells remaining on top. 

After detaching, you are now ready to proceed with your target cells. Our team of scientific experts is committed to the success of the researchers with whom we collaborate, and we look forward to providing you with our novel pluriBeads technology as yet another tool in your arsenal as you work toward the next big scientific breakthrough.